008930 — Hanmi Science Co Balance Sheet
0.000.00%
- KR₩3tn
 - KR₩3tn
 - KR₩1tn
 
- 73
 - 21
 - 31
 - 34
 
Annual balance sheet for Hanmi Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14,849 | 16,591 | 21,421 | 33,579 | 87,228 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 87,903 | 94,216 | 110,550 | 108,771 | 103,331 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 215,727 | 222,559 | 245,348 | 273,900 | 327,965 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25,641 | 26,044 | 88,919 | 94,068 | 100,353 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 923,220 | 949,894 | 1,109,691 | 1,226,170 | 1,349,079 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 220,113 | 220,995 | 347,726 | 395,202 | 468,827 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 264,484 | 259,596 | 384,945 | 438,663 | 508,150 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 658,736 | 690,298 | 724,746 | 787,507 | 840,929 | 
| Total Liabilities & Shareholders' Equity | 923,220 | 949,894 | 1,109,691 | 1,226,170 | 1,349,079 | 
| Total Common Shares Outstanding |